Clinical Trials

Information on Landos Biopharma’s studies of omilancor (BT-11), NX-13 and LABP-104 are available at ClinicalTrials.gov (external link opens in a new window).

Drug Study Phase
OmilancorGlobal Phase 2 Ulcerative Colitis study (external link opens in a new window)
OmilancorGlobal Phase 2 Crohn’s disease study (external link opens in a new window)
NX-13Global Phase 1b Ulcerative Colitis study (external link opens in a new window)
LABP-104Phase 1 Systemic Lupus Erythematosus (SLE) and rheumatoid arthritis (RA) study (external link opens in a new window)